On the 9th day after the establishment of the tumor model (2 days after the second VV treatment, that is, before the third VV treatment), the proportion of tumor cells in the ascites of mice treated with VV-Control or VV-α-TIGIT was significantly lower than that of mice treated with PBS (P <0.01; P < 0.001). This evidence concerns the gene TIGIT and neoplasm.